Using the gating strategy shown in Fig. S1A and based on CD5 and CD1d expression, we identified several Breg subsets in HCC/CaMIN (Fig. 2) and in MASLD and HCC/NRASG12V/p19Arf-/- (Fig. S2). This evidence concerns the gene CD5 and hepatocellular carcinoma.